Literature DB >> 33804590

Correction: Kis, Z. et al. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand. Vaccines 2021, 9, 3.

Zoltán Kis1, Cleo Kontoravdi1, Robin Shattock2, Nilay Shah1.   

Abstract

The authors wish to make the following corrections to this paper [...].

Entities:  

Year:  2021        PMID： 33804590      PMCID： PMC7999672          DOI： 10.3390/vaccines9030205

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN： 2076-393X


  5 in total

1.  Using Regulatory Stances to See All the Commercial Determinants of Health.

Authors:  Alex C Liber
Journal:  Milbank Q       Date:  2022-05-17       Impact factor: 6.237

Review 2.  mRNA vaccines manufacturing: Challenges and bottlenecks.

Authors:  Sara Sousa Rosa; Duarte M F Prazeres; Ana M Azevedo; Marco P C Marques
Journal:  Vaccine       Date:  2021-03-24       Impact factor: 4.169

Review 3.  The Pivotal Role of Chemical Modifications in mRNA Therapeutics.

Authors:  Albert Liu; Xiao Wang
Journal:  Front Cell Dev Biol       Date:  2022-07-13

Review 4.  Current Vaccine Platforms in Enhancing T-Cell Response.

Authors:  Takehiro Ura; Masaki Takeuchi; Tatsukata Kawagoe; Nobuhisa Mizuki; Kenji Okuda; Masaru Shimada
Journal:  Vaccines (Basel)       Date:  2022-08-21

5.  mRNA Innovates the Vaccine Field.

Authors:  Norbert Pardi
Journal:  Vaccines (Basel)       Date:  2021-05-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.